IL101705A - Acetone, 1-butanol, 1-propanol, and 2-propanol Suliths of dirithromycin and the process for their preparation - Google Patents

Acetone, 1-butanol, 1-propanol, and 2-propanol Suliths of dirithromycin and the process for their preparation

Info

Publication number
IL101705A
IL101705A IL10170592A IL10170592A IL101705A IL 101705 A IL101705 A IL 101705A IL 10170592 A IL10170592 A IL 10170592A IL 10170592 A IL10170592 A IL 10170592A IL 101705 A IL101705 A IL 101705A
Authority
IL
Israel
Prior art keywords
dirithromycin
solvate
propanol
acetone
solvent
Prior art date
Application number
IL10170592A
Other languages
English (en)
Hebrew (he)
Other versions
IL101705A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL101705A0 publication Critical patent/IL101705A0/xx
Publication of IL101705A publication Critical patent/IL101705A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Formation And Processing Of Food Products (AREA)
IL10170592A 1991-04-29 1992-04-24 Acetone, 1-butanol, 1-propanol, and 2-propanol Suliths of dirithromycin and the process for their preparation IL101705A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69284291A 1991-04-29 1991-04-29

Publications (2)

Publication Number Publication Date
IL101705A0 IL101705A0 (en) 1992-12-30
IL101705A true IL101705A (en) 1996-01-31

Family

ID=24782254

Family Applications (2)

Application Number Title Priority Date Filing Date
IL10170592A IL101705A (en) 1991-04-29 1992-04-24 Acetone, 1-butanol, 1-propanol, and 2-propanol Suliths of dirithromycin and the process for their preparation
IL101704A IL101704A (en) 1991-04-29 1992-04-27 Polymorph of dirithromycin and pharmaceutical preparations containing it

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL101704A IL101704A (en) 1991-04-29 1992-04-27 Polymorph of dirithromycin and pharmaceutical preparations containing it

Country Status (27)

Country Link
EP (2) EP0511800B1 (sh)
JP (2) JP3135672B2 (sh)
KR (2) KR100194307B1 (sh)
CN (2) CN1030611C (sh)
AT (2) ATE138924T1 (sh)
AU (2) AU646734B2 (sh)
BR (2) BR9201540A (sh)
CA (2) CA2067275C (sh)
CY (2) CY1946A (sh)
CZ (2) CZ282218B6 (sh)
DE (2) DE69214710T2 (sh)
DK (2) DK0511800T3 (sh)
ES (2) ES2093779T3 (sh)
FI (2) FI921876A (sh)
GR (2) GR3020439T3 (sh)
HK (2) HK153696A (sh)
HU (2) HU215917B (sh)
IE (2) IE76296B1 (sh)
IL (2) IL101705A (sh)
MX (2) MX9201944A (sh)
MY (2) MY109498A (sh)
NO (2) NO179504C (sh)
NZ (2) NZ242505A (sh)
RU (2) RU2070203C1 (sh)
TW (2) TW315371B (sh)
YU (2) YU44492A (sh)
ZA (2) ZA922777B (sh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW271400B (sh) * 1992-07-30 1996-03-01 Pfizer
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
IL127833A (en) * 1996-07-29 2004-06-20 Abbott Lab Preparation of the crystalline form II of clarithromycin
IL128845A0 (en) * 1996-09-24 2000-01-31 Lilly Co Eli Coated particle formulation
US6390690B1 (en) 2000-05-17 2002-05-21 3M Innovative Properties Company Fiber optic connector for coupling devices on intersecting planes
BRPI0719565A2 (pt) * 2006-12-05 2013-12-10 Pfizer Polimorfos de motilídeo
CN102145008B (zh) * 2010-12-29 2013-06-05 辰欣药业股份有限公司 一种地红霉素药物组合物及其制备方法
CN107151261B (zh) * 2017-06-09 2020-06-12 广州大光制药有限公司 一种地红霉素化合物的晶型及其结晶制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2515075C2 (de) * 1975-04-07 1985-10-24 Dr. Karl Thomae Gmbh, 7950 Biberach Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
NO179504C (no) 1996-10-23
HU213613B (en) 1997-08-28
HU9201398D0 (en) 1992-07-28
BR9201540A (pt) 1992-12-01
CS127792A3 (en) 1992-11-18
ZA922776B (en) 1993-10-15
TW315371B (sh) 1997-09-11
CA2067275C (en) 2002-11-26
HU215917B (hu) 1999-03-29
KR920019364A (ko) 1992-11-19
FI101795B (fi) 1998-08-31
CN1030611C (zh) 1996-01-03
RU2045953C1 (ru) 1995-10-20
NO921617D0 (no) 1992-04-27
FI921876A0 (fi) 1992-04-27
FI921877A0 (fi) 1992-04-27
JP3135672B2 (ja) 2001-02-19
NZ242505A (en) 1993-06-25
AU1525792A (en) 1992-11-05
DE69211220T2 (de) 1996-11-07
KR100193742B1 (ko) 1999-06-15
AU1525592A (en) 1992-11-05
NO180450C (no) 1997-04-23
DK0511800T3 (da) 1997-04-21
KR920019365A (ko) 1992-11-19
NO180450B (no) 1997-01-13
CA2067275A1 (en) 1992-10-30
ATE144425T1 (de) 1996-11-15
KR100194307B1 (ko) 1999-06-15
CY1946A (en) 1992-04-27
DE69214710D1 (de) 1996-11-28
HK215096A (en) 1996-12-13
NZ242506A (en) 1993-09-27
HU9203168D0 (en) 1992-12-28
IL101704A (en) 1998-02-22
ES2093779T3 (es) 1997-01-01
FI921877A (fi) 1992-10-30
NO921617L (no) 1992-10-30
IE921346A1 (en) 1992-11-04
ATE138924T1 (de) 1996-06-15
YU44492A (sh) 1994-06-24
JP3333545B2 (ja) 2002-10-15
NO921616D0 (no) 1992-04-27
MX9201946A (es) 1992-11-01
JPH05117289A (ja) 1993-05-14
ZA922777B (en) 1993-10-15
AU655978B2 (en) 1995-01-19
CN1069197C (zh) 2001-08-08
DE69211220D1 (de) 1996-07-11
BR9201541A (pt) 1992-12-01
CA2067274A1 (en) 1992-10-30
NO179504B (no) 1996-07-15
CN1066270A (zh) 1992-11-18
CZ282021B6 (cs) 1997-04-16
EP0511799A1 (en) 1992-11-04
NO921616L (no) 1992-10-30
HUT62595A (en) 1993-05-28
FI101795B1 (fi) 1998-08-31
MY109498A (en) 1997-02-28
EP0511800A1 (en) 1992-11-04
EP0511799B1 (en) 1996-06-05
DK0511799T3 (da) 1996-06-24
FI921876A (fi) 1992-10-30
GR3021706T3 (en) 1997-02-28
IE74885B1 (en) 1997-08-13
JPH05117154A (ja) 1993-05-14
AU646734B2 (en) 1994-03-03
IL101704A0 (en) 1992-12-30
RU2070203C1 (ru) 1996-12-10
CY1975A (en) 1997-09-05
DE69214710T2 (de) 1997-03-13
HUT63956A (en) 1993-11-29
ES2088098T3 (es) 1996-08-01
IE76296B1 (en) 1997-10-08
YU44392A (sh) 1994-12-28
HK153696A (en) 1996-08-16
TW216399B (sh) 1993-11-21
GR3020439T3 (en) 1996-10-31
IE921345A1 (en) 1992-11-04
CS127692A3 (en) 1992-11-18
IL101705A0 (en) 1992-12-30
EP0511800B1 (en) 1996-10-23
MY114226A (en) 2002-09-30
MX9201944A (es) 1992-11-01
CN1066186A (zh) 1992-11-18
CA2067274C (en) 2002-10-15
CZ282218B6 (cs) 1997-06-11

Similar Documents

Publication Publication Date Title
EP0984020B1 (en) Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof.
US5556839A (en) Form II Dirithromycin
RU2263117C2 (ru) Способ получения 4"-замещенных производных 9-деоксо-9а-аза-9а-гомоэритромицина а
CA2326930C (en) Preparation of non-crystalline and crystalline dihydrate forms of azithromycin
JP2002514171A (ja) クラリスロマイシンの結晶形態iiの製造
CA2067274C (en) Solvates of dirithromycin and a process for isolating form ii dirithromycin
JPH046715B2 (sh)
KR100375957B1 (ko) D4t 동질이상 i 형의 제조방법
CA2376748C (en) Diphosphate salt of a 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition
JPH09309896A (ja) コルヒチン誘導体をグリコシド化する方法、及びその生成物
IE46661B1 (en) Erythromycin a derivatives
JPS6219437B2 (sh)
US20050159371A1 (en) Process for producing erythromycin a derivative
RU2130942C1 (ru) Способ получения 3'-азидо-2', 3'-дидезокситимидина
CA2485433C (en) Preparation of non-crystalline and crystalline dihydrate forms of azithromycin

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed